Dan Chen
Login to view DISC.Dan Chen is the Vice President of Clinical Development at Axsome Therapeutics, with extensive experience leading drug development programs for CNS, respiratory, and gastrointestinal therapeutics. Holding both an MD and a PhD from Caltech, he has guided multiple therapies through crucial Phase III studies and successful regulatory submissions.
He played a key leadership role in the development and regulatory filing of Horizant®/solriamfetol, a significant treatment for excessive sleepiness in narcolepsy and OSA.
Read the full overview →How Dan shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Dan cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Other Axsome Therapeutics, Inc. Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.